RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 125 filers reported holding RA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $785,000 | +53.3% | 35,038 | +24.6% | 0.00% | 0.0% |
| Q4 2018 | $512,000 | -49.7% | 28,121 | -50.0% | 0.00% | 0.0% |
| Q3 2018 | $1,018,000 | +261.0% | 56,242 | +98.6% | 0.00% | – |
| Q2 2018 | $282,000 | +156.4% | 28,320 | +36.5% | 0.00% | – |
| Q1 2018 | $110,000 | -37.5% | 20,744 | 0.0% | 0.00% | – |
| Q4 2017 | $176,000 | -41.9% | 20,744 | 0.0% | 0.00% | – |
| Q3 2017 | $303,000 | -22.1% | 20,744 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $389,000 | +104.7% | 20,744 | +132.8% | 0.00% | – |
| Q1 2017 | $190,000 | +40.7% | 8,910 | 0.0% | 0.00% | – |
| Q4 2016 | $135,000 | – | 8,910 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 6,138,797 | $145,183,000 | 12.02% |
| VHCP Management III, LLC | 670,350 | $15,854,000 | 9.79% |
| RA Capital Management | 4,858,260 | $114,898,000 | 6.85% |
| VHCP Management II, LLC | 677,164 | $16,015,000 | 6.10% |
| EMORY UNIVERSITY | 59,690 | $1,412,000 | 2.78% |
| SECTORAL ASSET MANAGEMENT INC | 451,247 | $10,672,000 | 1.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,728,019 | $40,868,000 | 1.67% |
| Opaleye Management Inc. | 141,800 | $3,354,000 | 1.21% |
| ACUTA CAPITAL PARTNERS, LLC | 55,000 | $1,301,000 | 0.94% |
| EAM Global Investors LLC | 69,035 | $1,633,000 | 0.80% |